Vicente Anido, Jr.

2016

In 2016, Vicente Anido, Jr. earned a total compensation of $3.1M as Chief Executive Officer & Chairman of the Board at Aerie Pharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Bonus$329,410
Option Awards$1,785,900
Salary$549,016
Stock Awards$418,669
Total$3,082,995

Anido received $1.8M in option awards, accounting for 58% of the total pay in 2016.

Anido also received $329.4K in bonus, $549K in salary and $418.7K in stock awards.

Rankings

In 2016, Vicente Anido, Jr.'s compensation ranked 3,074th out of 14,075 executives tracked by ExecPay. In other words, Anido earned more than 78.2% of executives.

ClassificationRankingPercentile
All
3,074
out of 14,075
78th
Division
Manufacturing
1,070
out of 5,488
81st
Major group
Chemicals And Allied Products
314
out of 1,900
84th
Industry group
Drugs
229
out of 1,543
85th
Industry
Biological Products, Except Diagnostic Substances
49
out of 287
83rd
Source: SEC filing on April 27, 2017.

Anido's colleagues

We found three more compensation records of executives who worked with Vicente Anido, Jr. at Aerie Pharmaceuticals in 2016.

2016

Thomas Mitro

Aerie Pharmaceuticals

Chief Operating Officer

2016

Richard Rubino

Aerie Pharmaceuticals

Chief Financial Officer

2016

Casey Kopczynski

Aerie Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like